Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference
SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its […]
BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID
Authorization expands use of bezisterim in a Phase 2, placebo-controlled, multicenter trial assessing bezisterim’s impact on neurological symptoms associated with […]
UPDATE — Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming […]
Maris-Tech Receives U.S. Patent for Innovative Forward Error Correction Optimization Method
The patented method reduces overhead data required in the forward error correction process based on specific characteristics of streamed media […]
Affimed Appoints Shawn M. Leland as Chief Executive Officer
MANNHEIM, Germany, Sept. 03, 2024 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company […]
H World Group Limited Announces Change of Chief Financial Officer
SINGAPORE and SHANGHAI, Sept. 03, 2024 (GLOBE NEWSWIRE) — H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World” […]
Ocugen to Participate in a Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference
MALVERN, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused […]
MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, […]
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
While 9 out of 10 people with diabetes are living with T2D, many of the automated insulin delivery solutions currently […]
Bionomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
ADELAIDE, Australia, and CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology […]
